换一批Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.
第一作者：
Niklas,Klümper
第一单位：
Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.;Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;BRIDGE-Consortium Germany e.V., Mannheim, Germany.
作者：
Niklas,Klümper [1]
;
Damian J,Ralser [2]
;
Jörg,Ellinger [3]
;
Florian,Roghmann [4]
;
Julia,Albrecht [5]
;
Eduard,Below [6]
;
Abdullah,Alajati [3]
;
Danijel,Sikic [7]
;
Johannes,Breyer [8]
;
Christian,Bolenz [9]
;
Friedemann,Zengerling [9]
;
Philipp,Erben [10]
;
Kristina,Schwamborn [11]
;
Ralph M,Wirtz [12]
;
Thomas,Horn [13]
;
Dora,Nagy [14]
;
Marieta,Toma [14]
;
Glen,Kristiansen [15]
;
Thomas,Büttner [3]
;
Oliver,Hahn [16]
;
Viktor,Grünwald [17]
;
Christopher,Darr [17]
;
Eva,Erne [18]
;
Steffen,Rausch [18]
;
Jens,Bedke [18]
;
Katrin,Schlack [19]
;
Mahmoud,Abbas [20]
;
Stefanie,Zschäbitz [21]
;
Constantin,Schwab [22]
;
Alexander,Mustea [23]
;
Patrick,Adam [24]
;
Andreas,Manseck [25]
;
Bernd,Wullich [7]
;
Manuel,Ritter [26]
;
Arndt,Hartmann [27]
;
Jürgen,Gschwend [13]
;
Wilko,Weichert [11]
;
Franziska,Erlmeier [28]
;
Michael,Hölzel [6]
;
Markus,Eckstein [27]
作者单位：
Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.;Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;BRIDGE-Consortium Germany e.V., Mannheim, Germany.
[1]
Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;Department of Gynaecology and Gynaecological Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
[2]
Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
[3]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Department of Urology, Marien Hospital, Ruhr-University Bochum, Herne, Germany.
[4]
Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.;Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
[5]
Institute of Experimental Oncology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.
[6]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.;Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.;Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.
[7]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.;Department of Urology, University of Regensburg, Caritas St. Josef Hospital, Regensburg, Germany.
[8]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Department of Urology and Pediatric Urology, University Hospital Ulm, University of Ulm, Ulm, Germany.
[9]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Department of Urology and Urosurgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.
[10]
Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.;Institute of Pathology, Technical University Munich, Munich, Germany.
[11]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;STRATIFYER Molecular Pathology, Cologne, Germany.
[12]
Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.;Department of Urology, Technical University Munich, Munich, Germany.
[13]
Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;Institute of Pathology, University Medical Center Bonn (UKB), Bonn, Germany.
[14]
Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Institute of Pathology, University Medical Center Bonn (UKB), Bonn, Germany.
[15]
Department of Urology, University Medical Center Göttingen, Göttingen, Germany.
[16]
Clinic for Internal Medicine (Tumor Research) and Clinic for Urology, Interdisciplinary Genitourinary Oncology at the West-German Cancer Center, Essen University Hospital, Essen, Germany.
[17]
Department of Urology, Eberhard Karls University, Tübingen, Germany.
[18]
Department of Urology, University Hospital Münster, Münster, Germany.
[19]
Department of Pathology, University Hospital Münster, Münster, Germany.
[20]
Department of Medical Oncology, National Center for Tumor Disease (NCT), University Hospital, Heidelberg, Germany.
[21]
Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
[22]
Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;Department of Gynaecology and Gynaecological Oncology, University Medical Center Bonn (UKB), Bonn, Germany.
[23]
Pathologie Ingolstadt, Ingolstadt, Germany.
[24]
Department of Urology, Klinikum Ingolstadt, Ingolstadt, Germany.
[25]
Department of Urology and Pediatric Urology, University Medical Center Bonn (UKB), Bonn, Germany.;Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Germany.;BRIDGE-Consortium Germany e.V., Mannheim, Germany.
[26]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.;Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.;Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
[27]
BRIDGE-Consortium Germany e.V., Mannheim, Germany.;Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.;Bavarian Center for Cancer Research (Bayerisches Zentrum für Krebsforschung, BZKF), Erlangen, Germany.;Institute of Pathology, Technical University Munich, Munich, Germany.;Department of Urology, Eberhard Karls University, Tübingen, Germany.
[28]
医学主题词
人类(Humans);膀胱肿瘤(Urinary Bladder Neoplasms);癌, 移行细胞(Carcinoma, Transitional Cell);抗体, 单克隆(Antibodies, Monoclonal);细胞黏附分子(Cell Adhesion Molecules)
DOI
10.1158/1078-0432.CCR-22-1764
PMID
36534531
发布时间
2023-05-07
- 浏览3
Clinical cancer research
Clinical cancer research
1496-1505页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
